People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Biotechnology, Other Health Care, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Amicus Therapeutics, Inc. | — | Biotechnology | Series D+ | $314.5M | $420.8M | 2010 |
| Regado Biosciences Inc | — | Biotechnology | Series B | $141.7M | $793.8M | 2009 |
| Rapid Micro Biosystems, Inc. | — | Other Health Care | Series C | $134.6M | $1.4B | 2018 |
| Neuronetics, Inc. | — | Other Health Care | Series B | $118.7M | $332.3M | 2014 |
| Raindance Technologies Inc | — | Biotechnology | Series C | $105.7M | $1.7B | 2013 |
| Intact Vascular, Inc. | — | Other Health Care | Series B | $86.8M | $299.1M | 2013 |
| Biolex Therapeutics, Inc. | — | Biotechnology | Series A | $26.9M | $85.5M | 2010 |
| Vesper Medical, Inc. | — | Healthtech | Series B | $22.5M | $174.6M | 2016 |
P. Sherrill Neff at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside P. Sherrill Neff on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.